Se-methyl-seleno-L-cysteine

DIETARY_SUPPLEMENT2 trials

Sponsors

National Cancer Institute (NCI), Cancer Research UK

Conditions

Healthy, no Evidence of DiseaseLymphoma

Phase 1

Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients

CompletedNCT00489372

National Cancer Institute (NCI)Healthy, no Evidence of Disease

Start: 2007-07-31End: 2009-07-31Updated: 2014-11-14

Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment

WithdrawnNCT00829205

Cancer Research UKLymphoma

Start: 2009-01-31Updated: 2013-08-26